With musculoskeletal disease prevalence on the rise and industrywide shifts in site of care and treatment preferences, this market is due for significant changes. We’ve identified four key drivers that are reshaping the delivery of musculoskeletal care.

Download the report with strategic insights on the drivers below:

Cross-industry forces are aligning with patient and payer preferences to expedite the shift of MSK care not just to HOPD and ASCs, but also into the home setting.

CMS has announced its intentions to propagate wellentrenched MSK value-based payment models by extending and expanding CJR and implementing a new mandatory bundled payment model after the conclusion of BPCI Advanced.

Digital MSK offerings are poised to explode and alter the orthopedic landscape — but first, stakeholders must address reimbursement, physician buy-in, patient education, and health disparity challenges.

Unignorable health inequities — stemming from variation in disease prevalence and exacerbated by inequitable access to care across patient cohorts — are propelling more MSK programs to adopt health equity as a strategic imperative.